Market capitalization | $16.46m |
Enterprise Value | $1.01b |
P/E (TTM) P/E ratio | negative |
EV/Sales (TTM) EV/Sales | 13.34 |
P/S ratio (TTM) P/S ratio | 0.22 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 9.80% |
Revenue (TTM) Revenue | $75.99m |
EBIT (operating result TTM) EBIT | $-65.28m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
Dec '23 |
+/-
%
|
||
Revenue | 76 76 |
10%
10%
|
|
Gross Profit | -11 -11 |
53%
53%
|
|
EBITDA | -47 -47 |
19%
19%
|
EBIT (Operating Income) EBIT | -65 -65 |
16%
16%
|
Net Profit | -42 -42 |
42%
42%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. It provides radiotherapy and diagnostic equipment leasing services to hospitals; and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals, It operates through Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is headquartered in Beijing, China.
Head office | Cayman Islands |
CEO | Jianyu Yang |
Employees | 727 |
Founded | 2007 |
Website | www.concordmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.